𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Impact of body mass index on estradiol depletion by aromatase inhibitors in postmenopausal women with early breast cancer

✍ Scribed by Pfeiler, G; Königsberg, R; Hadji, P; Fitzal, F; Maroske, M; Dressel-Ban, G; Zellinger, J; Exner, R; Seifert, M; Singer, C; Gnant, M; Dubsky, P


Book ID
121464395
Publisher
Nature Publishing Group
Year
2013
Tongue
English
Weight
305 KB
Volume
109
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Summary of aromatase inhibitor clinical
✍ Aman U. Buzdar; R. Charles Coombes; Paul E. Goss; Eric P. Winer 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

Five years of adjuvant therapy with tamoxifen was considered the gold-standard treatment for postmenopausal women with estrogen receptor-positive breast cancer for many years. Data from a core group of clinical trials investigating the safety and efficacy of aromatase inhibitors (AIs) have challenge